NASDAQ: RYZB - RayzeBio, Inc. Common Stock

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Healthcare

Reporting RayzeBio, Inc. Common Stock

Capitalization

IFRS
Reporting Annual Quarterly
2020 2021 2022 2023 LTM 5 year average CAGR 5
Чистая прибыль, млрд $
-0.0069 -0.0294 -0.0686 -0.0635 -0.0635
EV, млрд $
-0.143 -0.0415 -0.1186
EBIT, млрд $
-0.0069 -0.0394 -0.0721
EBITDA, млрд $
-0.0067 -0.0389 -0.0706
Баланс стоимость, млрд $
-0.0028 -0.0546 -0.1113
FCF, млрд $
-0.0028 -0.0367 -0.0608 -0.0907 -0.0907
Операционный денежный поток, млрд $
-0.0023 -0.0311 -0.0517 -0.056 -0.056
Операционная прибыль, млрд $
-0.0069 -0.0394 -0.0721 -0.0757 -0.0757
Операционные расходы, млрд $
0.0069 0.0394 0.0721 0.0757 0.0757
CAPEX, млрд $
0.000461 0.0056 0.0091 0.0346 0.0346


Balance sheet

IFRS
Reporting Annual Quarterly
2020 2021 2022 2023 LTM 5 year average CAGR 5
Наличность, млрд $
0.1437 0.0506 0.1292
Short Term Investments $
0.0031 0.1486 0.1671
Total Receivables $
0.0000 0.0005 0.0005
Total Current Assets $
0.1471 0.2024 0.3
Чистые активы, млрд $
0.0012 0.0136 0.0244
Активы, млрд $
0.1484 0.2164 0.3248
Short Term Debt $
0.000763 0.0018 0.0011
Задолженность, млрд $
0.1513 0.271 0.4361
Чистый долг, млрд $
-0.143 -0.0415 -0.1186
Долг, млрд $
0.000763 0.0091 0.0106
Interest income $
0 0.000265 0.0035 0.0122
Чист. проц. доходы, млрд $
0 0.000265 0.0035 0.0122 0.0122
Амортизация, млрд $
0.000213 0.000455 0.0015


Share

IFRS
Reporting Annual Quarterly
2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
EPS -0.1716 -0.7304 -1.75 -3.82
Цена акции ао 62.17 62.49 62.49
Число акций ао, млн 40.31 40.31 39.22
FCF/акцию -0.0693 -0.911 -1.55


Efficiency

IFRS
Reporting Annual Quarterly
2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 244.12 102.58 82.72 29.22
ROA, % -4.66 -16.14 -25.35 9.39
ROS, % 0 0 0 0 23.20
ROCE, % -4.71 -18.73 -22.94 35.06
Operation Margin, % 0 0 0 0 27.00


Coefficients

IFRS
Reporting Annual Quarterly
2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/FCF
0 0 0 0 38.30
E/P
0 0 0 0 0.04
EV/EBITDA
21.31 1.07 1.68 24.22
EV/Ebit
20.66 1.05 1.64 0 0 0
EV/S
0 0 0 0 7.59
EV/FCF
51.19 1.13 1.95 0 0 0 44.10
Debt/EBITDA
-0.1137 -0.2327 -0.1497 0 0 0 0 2.24
Netdebt/Ebitda
21.31 1.07 1.68 0 0 0 0 1.14
Debt/Ratio
0.0051 0.0419 0.0325 0 0 0 0 0.23
Debt/Equity
-0.2693 -0.166 -0.095 0 0 0 0 2.62
Debt/Net Income
-0.1103 -0.3076 -0.1541 0 0 0 0 3.25
Бета
15.65 0 0 0 -0.62
Индекс Альтмана
0 0 0 0 -65.39


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 1.85


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe